Cargando…
At the center of cervical carcinogenesis: synergism between high-risk HPV and the hyperactivated YAP1
Human papillomavirus (HPV) is recognized as a necessary, but insufficient cause of cervical cancer. Recent in vitro and in vivo evidence from our laboratory demonstrate that hyperactivation of yes-associated protein 1 (YAP1) is sufficient to induce cervical carcinogenesis. We found that synergism be...
Autores principales: | Wang, Cheng, Davis, John S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736164/ https://www.ncbi.nlm.nih.gov/pubmed/31528691 http://dx.doi.org/10.1080/23723556.2019.1612677 |
Ejemplares similares
-
Role of HPV16 E1 in cervical carcinogenesis
por: Baedyananda, Fern, et al.
Publicado: (2022) -
Blockade of an innate immune amplifier to fight immune hyperactivation in COVID-19?
por: Kiemer, Alexandra K.
Publicado: (2020) -
Molecular mechanisms in progression of HPV-associated cervical carcinogenesis
por: Gupta, Sadhana M., et al.
Publicado: (2019) -
The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression
por: He, Chunbo, et al.
Publicado: (2015) -
Comment on “Will HPV vaccination prevent cervical cancer”
por: Zhang, Shaokai, et al.
Publicado: (2020)